// company-profile
Inhibikase Therapeutics, Inc.
IKTExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings51Insiders17
// api This Inhibikase Therapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
No insider activity recorded for IKT in the last 90 days.
Institutional Ownership
Top 13F-HR holders of Inhibikase Therapeutics, Inc. as of 2026-03-31
Total reported AUM
$190.5M
QoQ change
-4.3%
Reporting period
2026-03-31
#1
Sands Capital Alternatives, LLC
CIK 1846444
$21.9M
13.0M shares
#2
Soleus Capital Management, L.P.
CIK 1802630
$18.3M
10.9M shares
#3
Fairmount Funds Management LLC
CIK 1802528
$14.5M
8.6M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 21, 2026 | Cabell Christopher | IKT | Disposition | 338,282 | $0.00 | $0K |
| Feb 21, 2026 | Aurentz Vincent | IKT | Disposition | 255,299 | $0.00 | $0K |
| Feb 21, 2026 | Munshi Amit | IKT | Disposition | 19,089 | $0.00 | $0K |
| Jan 5, 2026 | McIntyre David | IKT | Award | 986,319 | $0.00 | $0K |
| Jan 5, 2026 | Iwicki Mark T | IKT | Award | 4,982,706 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.